05/10/2024
6:54 AM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
7:00 AM | Fusion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
6:30 AM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
6:52 AM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
6:54 AM | Fusion Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024
6:34 AM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
6:36 AM | Fusion Pharmaceuticals (Filer)
| Form DEFA14A | |
|
04/12/2024
4:02 PM | Fusion Pharmaceuticals (Filer)
| Form 8-K/A | |
04/12/2024
7:00 AM | Fusion Pharmaceuticals (Filer)
| Form 10-K/A | |
04/10/2024
3:42 PM | Fusion Pharmaceuticals (Filer)
| Form PREM14A | |
04/09/2024
3:10 PM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
8:10 AM | FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Fusion Pharmaceuticals (Subject)
| Form SC 13G/A | |
03/25/2024
4:29 PM | FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Fusion Pharmaceuticals (Subject)
| Form SC 13D | |
03/20/2024
5:08 PM | Fusion Pharmaceuticals (Subject)
HealthCap VII, L.P. (Filed by)
| Form SC 13D/A | |
03/20/2024
3:30 PM | Fusion Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/20/2024
3:10 PM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
3:14 PM | Fusion Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/19/2024
4:27 PM | ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
Fusion Pharmaceuticals (Subject)
| Form DFAN14A | |
03/19/2024
5:24 AM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
5:25 AM | Fusion Pharmaceuticals (Filer)
| Form DEFA14A | |
02/13/2024
8:34 PM | Avidity Partners Management LP (Filed by)
Fusion Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/19/2024
3:37 PM | Fusion Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
01/19/2024
3:10 PM | Fusion Pharmaceuticals (Filer)
| Form 424B5 | |
01/18/2024
9:11 AM | FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Fusion Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/05/2024
7:46 AM | Bobilev Dmitri (Reporting)
Fusion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
7:49 AM | Fusion Pharmaceuticals (Issuer)
Rawat Mohit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
7:51 AM | Burak Eric (Reporting)
Fusion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
7:52 AM | Crowley John J (Reporting)
Fusion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
7:54 AM | Fusion Pharmaceuticals (Issuer)
Leamon Christopher P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
7:41 AM | Fusion Pharmaceuticals (Issuer)
Valliant John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:45 PM | Flynn James E (Filed by)
Fusion Pharmaceuticals (Subject)
| Form SC 13G | |
12/14/2023
4:31 PM | Fusion Pharmaceuticals (Subject)
Khuong Chau Quang (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/08/2023
4:36 PM | Fusion Pharmaceuticals (Subject)
Khuong Chau Quang (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023
7:00 AM | Fusion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
6:45 AM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
4:20 PM | Avidity Partners Management LP (Filed by)
Fusion Pharmaceuticals (Subject)
| Form SC 13G | |
10/16/2023
3:59 PM | Bitetti Teresa Marie (Reporting)
Fusion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2023
4:00 PM | Fusion Pharmaceuticals (Issuer)
Meek David D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2023
3:48 PM | Bender Jeremy (Reporting)
Fusion Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2023
3:51 PM | Fusion Pharmaceuticals (Issuer)
Meek David D. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2023
3:30 PM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Bill Clinton Backing Biden Replacement??? (Ad) Bill Clinton is back.
And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August… Click here now for my urgent election forecast. |
08/08/2023
7:21 AM | Fusion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023
6:30 AM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2023
11:15 PM | Fusion Pharmaceuticals (Filer)
| Form EFFECT | |
06/20/2023
7:00 AM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
4:04 PM | Bergstrom Donald A (Reporting)
Fusion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:05 PM | CAGNONI PABLO J (Reporting)
Fusion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:06 PM | Duncan Barbara Gayle (Reporting)
Fusion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:07 PM | Fusion Pharmaceuticals (Issuer)
GANNON STEVEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:08 PM | Fusion Pharmaceuticals (Issuer)
Khuong Chau Quang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:09 PM | Fusion Pharmaceuticals (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:10 PM | Fusion Pharmaceuticals (Issuer)
Preston Heather (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
7:19 AM | FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Fusion Pharmaceuticals (Subject)
| Form SC 13G/A | |
05/16/2023
3:28 PM | Fusion Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
